Guangdong Zhongke Pharmaceutical Research Co., Ltd., established in 2005, is located in Guangzhou International Business Incubator, a high-tech enterprise. Its main business is the research and development of innovative small molecule chemical drugs. The company undertakes and completes two national major new drug creation projects, and jointly completes two national major new drug creation projects. In 2016, we jointly completed the national major new drug creation project "New Drug Creation Based on GPCR Structural Transformation" with Shanghai Institute of Pharmacy, Chinese Academy of Sciences, Peking University, etc., and undertook and completed two major science and technology projects in Guangdong, two major science and technology projects in Guangzhou, one national innovation fund, more than 30 patent authorizations, three clinical approvals of Class 1.1 new drugs, and four achievements of Class 1 new drugs, with a total transfer amount of 171 million yuan. Wang Wei, the founder of the company, once worked in DebioPharm, master of pharmacy, deputy chief pharmacist, expert of science and technology project evaluation in Guangdong and Guangzhou, and was selected as an outstanding expert of high-level talents in Guangzhou in 2019.